Clinical Trials News
Impax Labs sees success with Parkinson’s Drug
In a press release from March 2011 Impax Pharmaceuticals announced positive results of IPX066 in a Phase III clinical study testing the drug’s efficacy and safety. The study showed that IPX066 improved …